Jiayu Fu1,2, Ji He1,2, Wei Zhao3,4, Chuan Ren3,4, Ping Liu3,4, Lu Chen1,2, Dan Li3,4, Lu Tang1,2, Lequn Zhou3, Yixuan Zhang1,2, Xinran Ma1,2, Gaoqi Zhang1,2, Nan Li5, Dongsheng Fan6,7. 1. Department of Neurology, Peking University Third Hospital, 49 North Garden Road, Beijing, 100191, Haidian District, China. 2. Beijing Municipal Key Laboratory of Biomarker and Translational Research in Neurodegenerative Diseases, Beijing, China. 3. Department of Cardiology, Peking University Third Hospital, Beijing, China. 4. Physical Examination Center, Peking University Third Hospital, Beijing, China. 5. Clinical Epidemiology Research Center, Peking University Third Hospital, Beijing, China. 6. Department of Neurology, Peking University Third Hospital, 49 North Garden Road, Beijing, 100191, Haidian District, China. dsfan2010@aliyun.com. 7. Beijing Municipal Key Laboratory of Biomarker and Translational Research in Neurodegenerative Diseases, Beijing, China. dsfan2010@aliyun.com.
Abstract
BACKGROUND AND OBJECTIVE: Exploration of hypermetabolism in amyotrophic lateral sclerosis (ALS) with different ethnicities is needed to understand its metabolic implications for clinical management. We aimed to evaluate the features of hypermetabolism and investigate its association with clinical characteristics and prognosis of ALS in a prospective Chinese cohort. METHODS: This prospective study was conducted at Peking University Third Hospital, China from 2017 to 2020. 343 participants were enrolled initially. After strict screening, 147 matched health controls and 93 patients with ALS were eligible and underwent detailed clinical assessments. Disease severity and progression were evaluated using recognized scales. Metabolic assessments included body composition and metabolic index (MI) [hypermetabolism if MI ≥ 120.0%]. Patients were followed up every 6 months for survival analysis. RESULTS: Compared with controls, hypermetabolism was significantly more prevalent in ALS (p = 0.009). MI was consistently higher in ALS than controls (p = 0.009). Further correlation analysis showed that MI significantly decreased with disease progression, as graded by King's College staging system (p < 0.001). MI was significantly correlated with fat-free mass and fat mass (p = 0.005 and 0.007). Survival analysis showed that hypermetabolism independently indicated a worse prognosis for ALS (HR = 1.020, CI = 1.004-1.036, p = 0.013). CONCLUSION: A significant increase in the prevalence and degree of hypermetabolism was identified in ALS compared with strictly matched controls. Metabolic index, which is significantly associated with disease progression and body composition, is an independent prognostic indicator for a worse survival of ALS.
BACKGROUND AND OBJECTIVE: Exploration of hypermetabolism in amyotrophic lateral sclerosis (ALS) with different ethnicities is needed to understand its metabolic implications for clinical management. We aimed to evaluate the features of hypermetabolism and investigate its association with clinical characteristics and prognosis of ALS in a prospective Chinese cohort. METHODS: This prospective study was conducted at Peking University Third Hospital, China from 2017 to 2020. 343 participants were enrolled initially. After strict screening, 147 matched health controls and 93 patients with ALS were eligible and underwent detailed clinical assessments. Disease severity and progression were evaluated using recognized scales. Metabolic assessments included body composition and metabolic index (MI) [hypermetabolism if MI ≥ 120.0%]. Patients were followed up every 6 months for survival analysis. RESULTS: Compared with controls, hypermetabolism was significantly more prevalent in ALS (p = 0.009). MI was consistently higher in ALS than controls (p = 0.009). Further correlation analysis showed that MI significantly decreased with disease progression, as graded by King's College staging system (p < 0.001). MI was significantly correlated with fat-free mass and fat mass (p = 0.005 and 0.007). Survival analysis showed that hypermetabolism independently indicated a worse prognosis for ALS (HR = 1.020, CI = 1.004-1.036, p = 0.013). CONCLUSION: A significant increase in the prevalence and degree of hypermetabolism was identified in ALS compared with strictly matched controls. Metabolic index, which is significantly associated with disease progression and body composition, is an independent prognostic indicator for a worse survival of ALS.
Authors: Lu Chen; Bin Zhang; Ru Chen; Lu Tang; Rong Liu; Yan Yang; Yi Yang; Xiaolu Liu; Shan Ye; Siyan Zhan; Dongsheng Fan Journal: J Neurol Neurosurg Psychiatry Date: 2015-06-29 Impact factor: 10.154
Authors: Michael A van Es; Orla Hardiman; Adriano Chio; Ammar Al-Chalabi; R Jeroen Pasterkamp; Jan H Veldink; Leonard H van den Berg Journal: Lancet Date: 2017-05-25 Impact factor: 79.321
Authors: N Shahrizaila; G Sobue; S Kuwabara; S H Kim; Carol Birks; D S Fan; J S Bae; C J Hu; M Gourie-Devi; Y Noto; K Shibuya; K J Goh; R Kaji; C P Tsai; L Cui; P Talman; R D Henderson; S Vucic; M C Kiernan Journal: J Neurol Neurosurg Psychiatry Date: 2016-04-19 Impact factor: 10.154
Authors: M Nolano; V Provitera; F Manganelli; R Iodice; G Caporaso; A Stancanelli; K Marinou; B Lanzillo; L Santoro; G Mora Journal: Neuropathol Appl Neurobiol Date: 2016-07-07 Impact factor: 8.090
Authors: Frederik J Steyn; Zara A Ioannides; Ruben P A van Eijk; Susan Heggie; Kathryn A Thorpe; Amelia Ceslis; Saman Heshmat; Anjali K Henders; Naomi R Wray; Leonard H van den Berg; Robert D Henderson; Pamela A McCombe; Shyuan T Ngo Journal: J Neurol Neurosurg Psychiatry Date: 2018-04-29 Impact factor: 10.154